Trial intelligence / Profile preview

Effect of Oral Vitamin C on Inflammatory Biomarkers in Hemodialysis

NCT01356433Phase 4Completed

Sponsor
Peking University First Hospital
Start
Aug 2011
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ascorbic acid in uremia, inflammation, scurvy, sponsored by Peking University First Hospital. Started Aug 2011; status: completed.

02

Drugs

ascorbic acid
03

Conditions

uremiainflammationscurvy

Beyond the preview

Go deeper on NCT01356433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01356433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call